Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers

A. C. Andreotti, E. Pianezzola, S. Persiani, M. A. Pacciarini, M. Strolin Benedetti, A. E. Pontiroli

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences